Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)

NCT04687020 is registered in ClinicalTrials.gov with NS Pharma, Inc. as lead sponsor.

NCT NCT04687020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04687020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)
Lead sponsor
NS Pharma, Inc.
Phase
Phase 4
Overall status
Active, not recruiting
Start date
June 10, 2021
Completion date
October 31, 2032
Enrollment
9 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy